So it is clear that UQ has filed everything in time but they did not inform Prana at all. So it looks that patent will be granted one day but what will ATH get is open.
In January 2019 Prana filed in Australia an application " “Processes for the preparation of 8-Hydroxyquinoline Derivatives”. If this will make any difference to the old PBT2 patent, I cannot say anything. In any case, PBT2 has at least some value for a few years. Interesting to see how this will develop.
Ann: Appendix 4E & Annual Report 2019, page-9
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150000 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 792899 | 4 |
View Market Depth
| Last trade - 08.48am 12/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable